Hepatobiliary and Pancreatic Diseases International
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.9 | Q2 | 71.9% | 1.021 | Q1 | 84.4% |
| 2024 | 4.4 | Q1 | 81.6% | 0.964 | Q2 | 83.2% |
| 2023 | 3.6 | Q2 | 72.7% | 0.720 | Q2 | 76.5% |
| 2022 | 3.3 | Q3 | 64.5% | 0.691 | Q2 | 76.4% |
| 2021 | 3.4 | Q3 | 57.8% | 0.657 | Q2 | 75.7% |
| 2020 | — | — | 0.846 | Q2 | 81.3% | |
| 2019 | — | — | 0.661 | Q2 | 75.4% | |
| 2018 | — | — | 0.560 | Q3 | 68.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1499-3872
region
Asiatic Region
coverage
2002-2026